Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group "chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and Hepatology].
Reinisch W, Haas T, Kaser A, Petritsch W, Vogelsang H, Feichtenschlager T, Novacek G, Siebert F, Tilg H, Knoflach P. Reinisch W, et al. Among authors: kaser a. Z Gastroenterol. 2009 Apr;47(4):372-80. doi: 10.1055/s-0028-1109218. Epub 2009 Apr 8. Z Gastroenterol. 2009. PMID: 19358065 German.
[Infliximab therapy for Crohn's disease - a practical guideline: actualised consensus of the working group for chronic inflammatory bowel diseases of the Austrian Society for Gastroenterology and Hepatology].
Reinisch W, Dejaco C, Feichtenschlager T, Haas T, Kaser A, Miehsler W, Novacek G, Petritsch W, Platzer R, Tilg H, Vogelsang H, Knoflach P; Arbeitsgruppe Chronisch-entzündliche Darmerkrankungen der ÖGGH. Reinisch W, et al. Among authors: kaser a. Z Gastroenterol. 2011 Apr;49(4):534-42. doi: 10.1055/s-0029-1245930. Epub 2011 Mar 25. Z Gastroenterol. 2011. PMID: 21442574 German.
Antitumour necrosis factor therapy in Crohn's disease.
Tilg H, Kaser A. Tilg H, et al. Among authors: kaser a. Expert Opin Biol Ther. 2002 Oct;2(7):715-21. doi: 10.1517/14712598.2.7.715. Expert Opin Biol Ther. 2002. PMID: 12387670 Review.
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.
Miehsler W, Novacek G, Wenzl H, Vogelsang H, Knoflach P, Kaser A, Dejaco C, Petritsch W, Kapitan M, Maier H, Graninger W, Tilg H, Reinisch W; Austrian Society of Gastroenterology and Hepatology. Miehsler W, et al. Among authors: kaser a. J Crohns Colitis. 2010 Sep;4(3):221-56. doi: 10.1016/j.crohns.2009.12.001. Epub 2010 Mar 17. J Crohns Colitis. 2010. PMID: 21122513
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlager T, Fuchssteiner H, Knoflach P, Vogelsang H, Miehsler W, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Eichinger S. Novacek G, et al. Among authors: kaser a. Gastroenterology. 2010 Sep;139(3):779-87, 787.e1. doi: 10.1053/j.gastro.2010.05.026. Epub 2010 Jun 12. Gastroenterology. 2010. PMID: 20546736
Interferons and their role In inflammation.
Tilg H, Kaser A. Tilg H, et al. Among authors: kaser a. Curr Pharm Des. 1999 Oct;5(10):771-85. Curr Pharm Des. 1999. PMID: 10526087 Review.
256 results